Cargando…
Association Between Steroid-Sparing Therapy and the Risk of Perianal Fistulizing Complications Among Young Patients With Crohn Disease
IMPORTANCE: Perianal fistulizing complications (PFCs) develop in 15% to 30% of patients with Crohn disease (CD), are difficult to treat, worsen quality of life, increase cost of care, and commonly recur. Evidence-based strategies to prevent PFCs are lacking. OBJECTIVES: To investigate the effectiven...
Autores principales: | Adler, Jeremy, Lin, Chun Chieh, Gadepalli, Samir K., Dombkowski, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284306/ https://www.ncbi.nlm.nih.gov/pubmed/32515798 http://dx.doi.org/10.1001/jamanetworkopen.2020.7378 |
Ejemplares similares
-
Adenocarcinoma Arising from Perianal Fistulizing Crohn's Disease
por: Fornaro, Rosario, et al.
Publicado: (2018) -
Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022) -
Identifying perianal fistula complications in pediatric patients with Crohn’s disease using administrative claims
por: Adler, Jeremy, et al.
Publicado: (2019) -
Establishing a rabbit model of perianal fistulizing Crohn’s disease
por: Lu, Shuang-Shuang, et al.
Publicado: (2022) -
Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)